Cyclica is excited to welcome to its growing family Dr. Andreas Windemuth as Senior VP and Chief Scientist. Andreas brings to Cyclica 20 years of experience in computational biology, pharmacogenomics, and bioinformatics, and will be responsible for current and future developments around Cyclica’s Ligand Express™ proteome docking solution. Prior to joining Cyclica, Andreas served as Chief Information Officer at Firefly BioWorks, a biotechnology company started out of MIT, where he created all computational aspects of the company’s multiplexed assay technology.
Andreas oversaw algorithm and software development operations during the successful commercialization of the technology pre and post-acquisition by Abcam. Prior to Firefly, Andreas worked in leading scientific roles at three other start-up companies. Andreas is a fellow of the Boehringer Ingelheim Fonds (Stuttgart, Germany), and has done post-doctoral research on biomolecular modeling at the National Center for Supercomputing Applications and Columbia University. Andreas has coauthored over 60 peer-reviewed publications and is named inventor on 7 issued US patents.
Cyclica is excited to have Andreas on board to guide its scientific and technological growth.